Skip to content
StockMarketAgent
Direct answer
PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $8.05, high $14.0, with mid-point at $11.0.
Stock analysis

PATH UiPath Inc. fair value $11–$14

PATH
By StockMarketAgent.AI team· supervised by
Geanalyseerd: 2026-05-10Volgende update: 2026-08-10Methodology v2.4Archetype: Mature compounderNYSE · Information Technology
View archive
Koers
$10.79
▲ +0.19 (+1.76%)
Fair value
$11
$11–$14
Beoordeling
Aanhouden
confidence 84/100
Opwaarts potentieel
+1.8%
upside to fair value
Veiligheidsmarge
$9.33
buy below · 15%
Marktkapitalisatie
$5.7B
P/E fwd 12.0
Engelse bronNL
Engelse bron wordt weergegeven terwijl we vertalen
Dit rapport is nog niet vertaald. Vernieuw over een paar minuten zodra de vertaalwachtrij is bijgewerkt.

§1 Samenvatting

  • Composite fair value $11 with high case $14.
  • Implied upside of 1.8% to fair value.
  • Moat 6.5/10 · confidence 84/100 · Mature compounder.
  • Trades close to fair value, so the margin of safety is limited either way.
Fair value
$11
Margin of safety
+1.7%
Confidence
84/100
Moat
6.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$10.79Price
FV $10.98
High $13.97

PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • High switching costs embedded deep
    High switching costs embedded deep within enterprise legacy workflows.
  • Incumbent scale and broad integrations
    Incumbent scale and broad integrations in traditional RPA markets.
  • Cycle upside
    Enterprise AI adoption drives massive structural process orchestration needs across sectors.

§2 Berenscenario

A recessionary enterprise software budget freeze coupled with Microsoft bundling forces drastic pricing cuts. Base case growth of 9% plummets to 0%, while fixed R&D and SBCStock-based compensationThe fair-value cost of equity awards (options, RSUs, performance shares) granted to employees. A real economic expense even though it is non-cash. costs severely destroy GAAP margins.

Hoe deze these kan breken

AI Generative Disruption

· Medium

Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.

FV impact
Severe downside toward the FCFF DCF floor of $4.48 per share.
Trigger
12-24 months

Structural Margin Stagnation

· High

Intense competitive pricing pressure from Microsoft prevents operating margins from reaching the 25% terminal assumption.

FV impact
Fair value composite drops aggressively to the $8.05 bear case.
Trigger
24-36 months

Uncontrolled SBC Escalation

· Low

Inability to retain engineering talent forces higher stock-based compensation, permanently impairing free cash flow to equity.

FV impact
Resets terminal valuation multiple structurally below 15x.
Trigger
12-18 months
Vroege waarschuwingssignalen om te volgen
MetriekHuidigTrigger-drempel
Net revenue retention falling sustainably below the 110% threshold.MonitorDeterioration versus the report thesis
SBC remaining stubbornly above 18% of revenue without top-line acceleration.MonitorDeterioration versus the report thesis
Gross margin degradation below 80% indicating severe pricing pressure.MonitorDeterioration versus the report thesis
Operating margin trajectory missing the required 25% terminal target path.MonitorDeterioration versus the report thesis
Measurable market share loss in the standalone orchestration segment.MonitorDeterioration versus the report thesis

§3 Financiële historie

Winst-en-verliesrekening — laatste zes perioden
PostT−0T−1T−2T−3T−4CAGR
Periode2022-01-312023-01-312024-01-312025-01-312026-01-31Trend
Omzet$1.06B$1.31B$1.43B$1.61B+11.1%
Brutowinst$878.5M$1.11B$1.18B$1.34B+11.1%
Bedrijfsresultaat$-348.3M$-164.7M$-162.6M$56.8M
Nettowinst$-328.4M$-89.9M$-73.7M$282.3M
WPA (verwaterd)$-1.16$-0.60$-0.16$-0.13
EBITDA$-329.6M$-142.1M$-145.3M$73.7M
R&D$285.8M$332.1M$380.7M$385.2M+7.8%
VAA$941.1M$944.8M$964.6M$897.6M-1.2%

Kwaliteitsscores

Piotroski F-score
7 / 9
0–9 kwaliteitscomposiet
Altman Z-score
3.41
Faillissementsrisico (>3 veilig)
OCF / Nettowinst
1.32×
>1 wijst op hoge winstkwaliteit
Drempel boekhoudkwaliteit
Pass
Sector-aangepaste drempel
ROIC
2.1%
Rendement op geïnvesteerd kapitaal
Sectie 3

Numbers analysis

Individuele abonnees — vanaf §411 extra secties

Lees de volledige analyse — 11 extra secties.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Volledig rapport voor elke gedekte ticker
24 maanden rating-archief
Watchlist-briefings + rating-wijzigingsmeldingen
PDF + DOCX-export in elke taal
Start gratis proefperiode
Op elk moment opzegbaar.
FAQ

PATH — frequently asked questions

  1. Based on our latest analysis, PATH trades close to fair value. The current price is $10.8 versus a composite fair-value midpoint of $11.0 (range $8.05–$14.0), which implies roughly 1.8% upside to the midpoint.
Related coverage

Names readers of PATH also follow

Same archetype: mature-compounder
Same sector: Information Technology